Mercosur Bets On Joint Pricing Negotiations And Procurement For Lower Prices, But Slams Hep C Companies

Countries in South America have negotiated lower prices for the immunosuppressant tacrolimus and have their sights on high-cost oncology treatments. However, they have slammed companies selling new hepatitis C treatments for their inflexibility.

MERCOSUR flag Isolated Silk waving flags MERCOSUR Brazil Argentina Paraguay Uruguay Venezuela five members with a flagpole on a white background 3D illustration
Mercosur Members Look To Joint Price Negotiations and Purchasing • Source: Shutterstock

The Mercosur countries are continuing to try and achieve lower medicine prices through joint price negotiations purchasing. Ministers from the Latin American trade bloc recently announced a new lower price for the immunosuppressant tacrolimus and say high-cost oncology treatments could be next.

Mercosur members and associate countries include some of the region’s most important markets. Brazil and Argentina are full members, while...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access